Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

Clinical trial NCT00461929 · TERMINATED

Trial details

NCT number: NCT00461929
Sponsor: University Health Network, Toronto
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Gastrointestinal Stromal Cell Tumors Chromosome Abnormality

Start date: 2005-02-01
Primary completion: 2008-12-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.